Clinical characteristic and in-hospital mortality of avr st elevation myocardial infarction
Keywords:
aVR, Multivessel disease, ElectrocardiogramAbstract
Background: ST segment elevation (STE) in aVR (STE-aVR) is a less recognized finding and its clinical course is more severe and has a fewer prevalence than other walls of myocardial infarction and gives anticipation of early prognosis in some published evidences. Aim: To study clinical characteristics and in-hospital mortality in STE-aVR among Mongolian patients with acute myocardial infarction. Materials and Methods: This cross sectional study is based on patient’s medical records which admitted to coronary care unit of Shastin central hospital, Mongolia in 2019. Results: Total 554 patients records with acute coronary syndrome and 76.4% (n=423) of them were male, 75.1% were STEMI and among those STE-aVR were n=71. Total hospital length in non STE-aVR and STE-aVR group was 4.3±2.9 vs 5.56±4.1, respectively (p<0.001). Respiratory rate (RR) and SpO2 at hospital admission between 2 groups was RR: 18.9±3.6 vs 18.1±1.7 (p<0.001); SpO2: 92.3±7.8% vs 94.6±4.4% (p<0.001). Killip IV class cardiogenic shock was more observed in STE-aVR group compared to control group (25.7% vs 9.4%, p<0.001). Early cardiac arrest was also more frequently observed in STE-aVR group (6% vs 1.7%, p<0.03). Prevalence of multiple vessel disease was higher in STEaVR group (61.5% vs 39.1% p<0.001). In-hospital mortality was significantly higher in STE-aVR group compared to non-STE-aVR group (21.1% vs 8.6%, p<0.001). Conclusion: According to our study results, STE-aVR acute coronary syndrome’s clinical course is more severe, frequency and prevalence of cardiogenic shock and multiple vessel disease is higher and has a higher in-hospital mortality compared to non-STE-aVR acute coronary syndrome.
In the MNUMS Digital Library
View this article in the digital library →
Author research profiles: М.Мөнхзол
Downloads
Published
Issue
Section
License
Articles in this journal are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Anyone may copy, distribute and adapt the work, provided the authors and the source are properly credited. Copyright remains with the authors.
